Combination immunosuppressive therapy in pediatric severe aplastic anemia: trends in response and clinical outcomes

Uaprasert N, Chansung K, Pongtanakul B, Lauhasurayotin S, Sirachainan N, Visuthisakchai S, et al. Guideline for diagnosis and management of aplastic anemia in Thailand 2020. J Hematol Transfus Med. 2020;30:405-13.

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, et al. Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med. 2022;386:11-23.

Shimamura A, Maschan A, Bennett C, Samarasinghe S, Farrar JE, Li CK, et al. Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial. Blood Adv. 2025;9:3728-38.

Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X, et al. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia. Front Pediatr. 2023;10:1095143.

Scheinberg P. Activity of eltrombopag in severe aplastic anemia. Blood Adv 2018;2:3054-62